Clinical Trials in San Antonio

Showing 9361-9380 of 14,633 trials

The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers

NCT04019652

This study will test if a study drug (CS-3150) will affect the heart rate in healthy males and females. Two doses of the study drug will be tested. Heart rate is not expected to be different between the study groups.

HypertensionMineralocorticoid Receptor Antagonist

Daiichi Sankyo55 participantsStarted Nov 2015

San Antonio, Texas, United States

TERMINATEDPhase 2< 1 mile

Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

NCT03676231

This is a multicenter, randomized, double-blind, placebo-controlled study evaluating the safety, pharmacokinetics, and pharmacodynamics of 12 weeks' administration of SGM-1019 in subjects with fibrosis stage 1-3 (F1-F3) NASH.

Nonalcoholic Steatohepatitis

Second Genome9 participantsStarted Jan 2019

Chandler, Arizona, United States • Tucson, Arizona, United States • Panorama City, California, United States +7 more locations

UNKNOWN< 1 mile

Seizure Detection and Warning System for Epilepsy Patients

NCT01874600

The seizure detection and warning system is an ambulatory system designed to monitor and analyze EMG data to detect the onset of GTC seizures and to provide a warning signal to alert caregivers that a seizure is occurring.

Epilepsy

Brain Sentinel239 participantsStarted Jul 2013

San Antonio, Texas, United States

The Effect of CS-3150 Exposure on Corrected QT (QTc) Interval Duration in Healthy Volunteers

Study of SGM-1019 in Patients With Nonalcoholic Steatohepatitis (NASH)

Seizure Detection and Warning System for Epilepsy Patients

Find Trials by Condition in San Antonio

Case Selection and Treatment Protocol for Immediate Dental Implants in the Esthetic Zone

Evaluation of the Efficacy, Durability, Safety, and Tolerability of RP-G28 in Patients With Lactose Intolerance

S0702: Osteonecrosis of the Jaw in Patients With Cancer Receiving Zoledronic Acid for Bone Metastases

Open-label Extension (OLE) Study of Plecanatide for Chronic Idiopathic Constipation (CIC)

Study Of The Effectiveness & Safety Of Lenalidomide Versus Chlorambucil As First Line Therapy For Elderly Patients With B-Cell CLL (The ORIGIN Trial)

Post- Approval Study on Patients Who Received a HeartWare HVAD® During IDE Trials

Investigate Safety, Pharmacokinetics and Pharmacodynamics of GSK2118436 & GSK1120212

Laboratory-Treated Lymphocyte Infusion After Haploidentical Donor Stem Cell Transplant

AD-4833/TOMM40_303 Extension Study of the Safety and Efficacy of Pioglitazone to Slow Cognitive Decline in Participants With Mild Cognitive Impairment Due to Alzheimer Disease

A Study Evaluating Trastuzumab Emtansine Plus Pertuzumab Compared With Chemotherapy Plus Trastuzumab and Pertuzumab for Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Breast Cancer

Efficacy and Safety Study of Idelalisib in Participants With Indolent B-Cell Non-Hodgkin Lymphomas

A Study of Intratumoral CAVATAK™ in Patients With Stage IIIc and Stage IV Malignant Melanoma (VLA-007 CALM )

ATHENA: Natural History of Disease Study in Alport Syndrome Patients

Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD)

Phase II Study of the Effects of rhPDGF-BB Injection on Lateral Epicondylitis

Standard Dose Versus High Dose and Versus Extended Standard Dose Radium-223 Dichloride in Castration-resistant Prostate Cancer Metastatic to the Bone

Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection